prof. Veerle Surmont

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Lotte van der Weijst (UGent) , David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 176. p.127-137

Add to list

Journal Article
A1
open access

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Lotte van der Weijst (UGent) , Miguel E. Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Jenny Chang-Claude, Ananya Choudhury, et al.

(2022) LUNG CANCER. 166. p.228-241

Add to list

Journal Article
A2
open access

Neurocognitive functioning following lung cancer treatment : the PRO-Long study

Lotte van der Weijst (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) and Wim Schrauwen (UGent)

(2022) TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY. 21. p.36-40

Add to list

Journal Article
A1
open access

Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome

Malaïka Van der Linden (UGent) , Bram Van Gaever (UGent) , Lennart Raman, Karim Vermaelen (UGent) , Ingel Demedts (UGent) , Veerle Surmont (UGent) , Ulrike Himpe, Yolande Lievens (UGent) , Liesbeth Ferdinande (UGent) , Franceska Dedeurwaerdere, et al.

(2022) CANCERS. 14(8).

Add to list

Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials

Solange Peters, Sarah Danson, Dunson Ejedepang, Urania Dafni, Baktiar Hasan, Hoi-Shen Radcliffe, Frederique Bustin, Jacky Crequit, Linda Coate, Monica Guillot, et al.

(2021) LUNG CANCER. 161. p.76-85

Add to list

Journal Article
A1
open access

Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study

Lotte van der Weijst (UGent) , Veerle Surmont (UGent) , Wim Schrauwen (UGent) and Yolande Lievens (UGent)

(2021) FRONTIERS IN ONCOLOGY. 11.

Add to list

Coping strategy influences quality of life in patients with advanced lung cancer by mediating mood

Mick van de Wiel, Sofie Derijcke, Daniella Galdermans, Marc Daenen, Veerle Surmont (UGent) , Els De Droogh, Anneke Lefebure, Erika Saenen, Elke Vandenbroucke, Ann-Marie Morel, et al.

(2021) CLINICAL LUNG CANCER. 22(2). p.146-152

Add to list

Miscellaneous

Lung cancer in Belgium

Sebahat Ocak, Kurt Tournoy (UGent) , Thierry Berghmans, Ingel Demedts (UGent) , Rodolphe Durieux, Annelies Janssens, Luigi Moretti, Kristiaan Nackaerts, Thierry Pieters, Veerle Surmont (UGent) , et al.

(2021) RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY. 16(10). p.1610-1621

Add to list

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu Spaas (UGent) , Nora Sundahl, Sylvie Rottey (UGent) , VIBEKE KRUSE (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Piet Dirix, Veerle Surmont (UGent) , Yolande Lievens (UGent) , Robin Van den Begin, et al.

(2021) ESTRO 2021, Abstracts. 161(S1). p.S490-S491

Add to list

Journal Article
A1
open access

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).

Academic Bibliography

prof. Veerle Surmont

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Neurocognitive functioning following lung cancer treatment : the PRO-Long study

Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome

Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials

Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study

Coping strategy influences quality of life in patients with advanced lung cancer by mediating mood

Lung cancer in Belgium

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Contents

Support

Contact